Peter Kabos
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- MicroRNA in disease regulation
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Breast Cancer Treatment Studies 20
- MicroRNA in disease regulation 3
- Oncology 27
- Cancer Cells and Metastasis 13
- HER2/EGFR in Cancer Research 6
- Cancer-related Molecular Pathways 3
- Co-authors
- Carol A. Sartorius (28 shared papers)ANTHONY D. ELIAS (16 shared papers)Austin E. Gillen (11 shared papers)Jessica Finlay-Schultz (12 shared papers)Joshua Chuck Harrell (5 shared papers)Diana M. Cittelly (9 shared papers)Kathryn B. Horwitz (3 shared papers)Manoj M. Pillai (4 shared papers)
- Journals
- Clinical Cancer Research (10 papers)Breast Cancer Research and Treatment (5 papers)Breast Cancer Research (4 papers)Annals of Oncology (4 papers)npj Breast Cancer (4 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Peter Kabos
84 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 90
- Cancer Research 769
- Oncology 834
- Pulmonary and Respiratory Medicine 694
- Genetics 364
- Cell Biology 149
Countries citing papers authored by Peter Kabos
This map shows the geographic impact of Peter Kabos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kabos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kabos more than expected).
Fields of papers citing papers by Peter Kabos
This network shows the impact of papers produced by Peter Kabos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kabos. The network helps show where Peter Kabos may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Kabos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 223 | |
| 2 | 2020 | 208 | |
| 3 | 2016 | 206 | |
| 4 | 2016 | 187 | |
| 5 | 2020 | 168 | |
| 6 | 2017 | 133 | |
| 7 | 2012 | 115 | |
| 8 | 2008 | 113 | |
| 9 | 2010 | 95 | |
| 10 | 2021 | 82 | |
| 11 | 2012 | 81 | |
| 12 | 2022 | 74 | |
| 13 | 2014 | 70 | |
| 14 | 2013 | 67 | |
| 15 | 2014 | 64 | |
| 16 | 2015 | 64 | |
| 17 | 2018 | 64 | |
| 18 | 2019 | 64 | |
| 19 | 2014 | 55 | |
| 20 | 2017 | 54 |
About Peter Kabos
Peter Kabos is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Genetics and Molecular Biology, having authored 88 papers that have together received 3.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (20 papers), Advanced Breast Cancer Therapies (18 papers), Cancer Cells and Metastasis (13 papers), Estrogen and related hormone effects (13 papers), Brain Metastases and Treatment (10 papers), HER2/EGFR in Cancer Research (6 papers), Cancer-related Molecular Pathways (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (769 citations), Oncology (834 citations), Pulmonary and Respiratory Medicine (694 citations), Genetics (364 citations) and Cell Biology (149 citations). Peter Kabos has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Carol A. Sartorius, ANTHONY D. ELIAS, Austin E. Gillen, Jessica Finlay-Schultz, Joshua Chuck Harrell, Diana M. Cittelly, Kathryn B. Horwitz, Manoj M. Pillai, Virginia F. Borges and Heather M. Brechbuhl. Their work appears in journals such as Clinical Cancer Research, Breast Cancer Research and Treatment, Breast Cancer Research, Annals of Oncology and npj Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.